Cartesian Therapeutics Inc. (RNAC) stock news · rev $2.8M
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
This RNAC news page leads with what Cartesian Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for RNAC yet. We will not pad this page with generic market recap.
Latest reported RNAC revenue for 2025-12-31 was $2.8M. Net income was -$130.3M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. RNAC currently screens at market cap $290.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RNAC stock page; for the tape open the quote page.
RNAC stock news FAQ
What are RNAC's latest revenue and net income?
Latest cached Cartesian Therapeutics Inc. (RNAC) revenue for Dec 31, 2025 was $2.8M. Net income was -$130.3M. Statements: https://lician.com/financials/rnac
How did RNAC revenue change from the prior cached period?
Cached Cartesian Therapeutics Inc. (RNAC) revenue was down 92.8% from $38.9M (Dec 31, 2024) to $2.8M (Dec 31, 2025). Statements: https://lician.com/financials/rnac
What is RNAC's market cap?
Cartesian Therapeutics Inc. (RNAC) market cap is $290.9M on the latest cached fundamentals snapshot.
What kind of company is RNAC?
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Where is RNAC stock news listed?
Cached stock news for Cartesian Therapeutics Inc. (RNAC) is listed at https://lician.com/news/rnac. Filings: https://lician.com/sec/rnac
Not investment advice.